February 16th, 2005
Private Markets
Abstract:
enture funding for nanotechnology dropped from $386 million in 2002 to $200 million in 2004, according to New York City–based nanotech market research firm Lux Research. That means nanotech startups are finding it harder to do research in areas that could have tremendous long-range impact: new nanomaterials for optics and chip-cooling systems; biological diagnostics based on ultrasensitive nanosensors; and smart, automated delivery systems for protein drugs. "Over the years, the financial community has pushed for shorter-term results," says Peter Garcia, chief financial officer of Nanosys, a nanotech startup based in Palo Alto, CA. "There are projects that are more long term technically that have the greatest potential to change how products are made, but the funding is not there."
Source:
technologyreview
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||